{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:56:36Z","timestamp":1789602996334,"version":"build-2803163510"},"reference-count":188,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T00:00:00Z","timestamp":1555113600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s13402-019-00442-2","type":"journal-article","created":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T01:03:37Z","timestamp":1555117417000},"page":"405-421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Curcumin: a potent agent to reverse epithelial-to-mesenchymal transition"],"prefix":"10.1007","volume":"42","author":[{"given":"Afsane","family":"Bahrami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,13]]},"reference":[{"key":"442_CR1","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1002\/jcp.25952","volume":"233","author":"A Bahrami","year":"2018","unstructured":"A. Bahrami, A. Hesari, M. Khazaei, S.M. Hassanian, G.A. Ferns, A. Avan, The therapeutic potential of targeting the BRAF mutation in patients with colorectal cancer. J Cell Physiol. 233, 2162\u20132169 (2018)","journal-title":"J Cell Physiol."},{"key":"442_CR2","doi-asserted-by":"crossref","unstructured":"F. Bocci, H. Levine, J.N. Onuchic and M.K. Jolly Deciphering the dynamics of epithelial-mesenchymal transition and cancer stem cells in tumor progression, arXiv preprint arXiv:1808.09113, (2018)","DOI":"10.1007\/s40778-019-0150-3"},{"key":"442_CR3","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"J.P. Thiery, H. Acloque, R.Y. Huang, M.A. Nieto, Epithelial-mesenchymal transitions in development and disease. Cell 139, 871\u2013890 (2009)","journal-title":"Cell"},{"key":"442_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ceb.2016.06.002","volume":"43","author":"M Diepenbruck","year":"2016","unstructured":"M. Diepenbruck, G. Christofori, Epithelial\u2013mesenchymal transition (EMT) and metastasis: yes, no, maybe? Curr Opin Cell Biol. 43, 7\u201313 (2016)","journal-title":"Curr Opin Cell Biol."},{"key":"442_CR5","doi-asserted-by":"crossref","unstructured":"L. Ombrato, I. Malanchi, The EMT universe: space between cancer cell dissemination and metastasis initiation. Crit Rev Oncog. 19, 349\u2013361 (2014)","DOI":"10.1615\/CritRevOncog.2014011802"},{"key":"442_CR6","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1038\/onc.2013.128","volume":"33","author":"H Zheng","year":"2014","unstructured":"H. Zheng, Y. Kang, Multilayer control of the EMT master regulators. Oncogene 33, 1755 (2014)","journal-title":"Oncogene"},{"key":"442_CR7","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/j.biocel.2007.07.011","volume":"39","author":"M Guarino","year":"2007","unstructured":"M. Guarino, Epithelial\u2013mesenchymal transition and tumour invasion. Int J Biochem Cell Biol. 39, 2153\u20132160 (2007)","journal-title":"Int J Biochem Cell Biol."},{"key":"442_CR8","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.3748\/wjg.14.3792","volume":"14","author":"A Natalwala","year":"2008","unstructured":"A. Natalwala, R. Spychal, C. Tselepis, Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract. World J Gastroenterol. 14, 3792 (2008)","journal-title":"World J Gastroenterol."},{"key":"442_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1166\/ch.2013.1004","volume":"1","author":"Y Wang","year":"2013","unstructured":"Y. Wang, B.P. Zhou, Epithelial-mesenchymal transition\u2014a hallmark of breast cancer metastasis. Cancer Hallm. 1, 38\u201349 (2013)","journal-title":"Cancer Hallm."},{"key":"442_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s13402-017-0328-6","volume":"40","author":"A Fortunato","year":"2017","unstructured":"A. Fortunato, The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells. Cell Oncol. 40, 367\u2013378 (2017)","journal-title":"Cell Oncol."},{"key":"442_CR11","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1177\/1534735415588930","volume":"14","author":"AY-L Lee","year":"2015","unstructured":"A.Y.-L. Lee, C.-C. Fan, Y.-A. Chen, C.-W. Cheng, Y.-J. Sung, C.-P. Hsu, T.-Y. Kao, Curcumin inhibits invasiveness and epithelial-mesenchymal transition in oral squamous cell carcinoma through reducing matrix metalloproteinase 2, 9 and modulating p53-E-cadherin pathway. Integr Cancer Ther. 14, 484\u2013490 (2015)","journal-title":"Integr Cancer Ther."},{"key":"442_CR12","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.3892\/or.2016.4669","volume":"35","author":"Z Zhang","year":"2016","unstructured":"Z. Zhang, H. Chen, C. Xu, L. Song, L. Huang, Y. Lai, Y. Wang, H. Chen, D. Gu, L. Ren, Curcumin inhibits tumor epithelial-mesenchymal transition by downregulating the Wnt signaling pathway and upregulating NKD2 expression in colon cancer cells. Oncol Rep. 35, 2615\u20132623 (2016)","journal-title":"Oncol Rep."},{"key":"442_CR13","first-page":"541695","volume":"2013","author":"C-C Chen","year":"2013","unstructured":"C.-C. Chen, M. Sureshbabul, H.-W. Chen, Y.-S. Lin, J.-Y. Lee, Q.-S. Hong, Y.-C. Yang, S.-L. Yu, Curcumin suppresses metastasis via Sp-1, FAK inhibition, and E-cadherin upregulation in colorectal cancer. Evid Based Complement Alternat Med. 2013, 541695 (2013)","journal-title":"Evid Based Complement Alternat Med."},{"key":"442_CR14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1158\/1538-7445.AM2017-LB-125","volume":"7","author":"Q Wang","year":"2017","unstructured":"Q. Wang, C. Qu, F. Xie, L. Chen, L. Liu, X. Liang, X. Wu, P. Wang, Z. Meng, Curcumin suppresses epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells by inhibiting cancer-associated fibroblasts. Am J Cancer Res. 7, 125 (2017)","journal-title":"Am J Cancer Res."},{"key":"442_CR15","doi-asserted-by":"publisher","first-page":"e50165","DOI":"10.1371\/journal.pone.0050165","volume":"7","author":"B Bao","year":"2012","unstructured":"B. Bao, S. Ali, A. Ahmad, A.S. Azmi, Y. Li, S. Banerjee, D. Kong, S. Sethi, A. Aboukameel, S.B. Padhye, Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment. PloS one 7, e50165 (2012)","journal-title":"PloS one"},{"key":"442_CR16","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.3892\/or.2013.2385","volume":"29","author":"X-D Sun","year":"2013","unstructured":"X.-D. Sun, X.-E. Liu, D.-S. Huang, Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway. Oncol Rep. 29, 2401\u20132407 (2013)","journal-title":"Oncol Rep."},{"key":"442_CR17","first-page":"1593","volume":"52","author":"W Li","year":"2018","unstructured":"W. Li, Z. Jiang, X. Xiao, Z. Wang, Z. Wu, Q. Ma, L. Cao, Curcumin inhibits superoxide dismutase-induced epithelial-to-mesenchymal transition via the PI3K\/Akt\/NF-\u03baB pathway in pancreatic cancer cells. Int J Oncol. 52, 1593\u20131602 (2018)","journal-title":"Int J Oncol."},{"key":"442_CR18","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/labinvest.2015.107","volume":"95","author":"D Kong","year":"2015","unstructured":"D. Kong, F. Zhang, J. Shao, L. Wu, X. Zhang, L. Chen, Y. Lu, S. Zheng, Curcumin inhibits cobalt chloride-induced epithelial-to-mesenchymal transition associated with interference with TGF-\u03b2\/Smad signaling in hepatocytes. Lab Invest. 95, 1234 (2015)","journal-title":"Lab Invest."},{"key":"442_CR19","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.3892\/mmr.2014.2551","volume":"10","author":"W Duan","year":"2014","unstructured":"W. Duan, Y. Chang, R. Li, Q. Xu, J. Lei, C. Yin, T. Li, Y. Wu, Q. Ma, X. Li, Curcumin inhibits hypoxia inducible factor-1\u03b1-induced epithelial-mesenchymal transition in HepG2 hepatocellular carcinoma cells. Mol Med Rep. 10, 2505\u20132510 (2014)","journal-title":"Mol Med Rep."},{"key":"442_CR20","doi-asserted-by":"crossref","first-page":"108498","DOI":"10.18632\/oncotarget.22590","volume":"8","author":"M-T Cao","year":"2017","unstructured":"M.-T. Cao, H.-F. Liu, Z.-G. Liu, P. Xiao, J.-J. Chen, Y. Tan, X.-X. Jiang, Z.-C. Jiang, Y. Qiu, H.-J. Huang, Curcumin downregulates the expression of Snail via suppressing Smad2 pathway to inhibit TGF-\u03b21-induced epithelial-mesenchymal transitions in hepatoma cells. Oncotarget 8, 108498 (2017)","journal-title":"Oncotarget"},{"key":"442_CR21","doi-asserted-by":"publisher","first-page":"10388","DOI":"10.1021\/acs.jafc.5b04415","volume":"63","author":"C-F Tsai","year":"2015","unstructured":"C.-F. Tsai, T.-H. Hsieh, J.-N. Lee, C.-Y. Hsu, Y.-C. Wang, K.-K. Kuo, H.-L. Wu, C.-C. Chiu, E.-M. Tsai, P.-L. Kuo, Curcumin suppresses phthalate-induced metastasis and the proportion of cancer stem cell (CSC)-like cells via the inhibition of AhR\/ERK\/SK1 signaling in hepatocellular carcinoma. J Agric Food Chem. 63, 10388\u201310398 (2015)","journal-title":"J Agric Food Chem."},{"key":"442_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/scrt506","volume":"5","author":"S Mukherjee","year":"2014","unstructured":"S. Mukherjee, M. Mazumdar, S. Chakraborty, A. Manna, S. Saha, P. Khan, P. Bhattacharjee, D. Guha, A. Adhikary, S. Mukhjerjee, Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin\/\u03b2-catenin negative feedback loop. Stem Cell Res Ther. 5, 116 (2014)","journal-title":"Stem Cell Res Ther."},{"key":"442_CR23","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.3892\/ijo.2016.3477","volume":"48","author":"M Gallardo","year":"2016","unstructured":"M. Gallardo, G.M. Calaf, Curcumin and epithelial-mesenchymal transition in breast cancer cells transformed by low doses of radiation and estrogen. Int J Oncol. 48, 2534\u20132542 (2016)","journal-title":"Int J Oncol."},{"key":"442_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3892\/or.2012.2080","volume":"29","author":"T Huang","year":"2013","unstructured":"T. Huang, Z. Chen, L. Fang, Curcumin inhibits LPS-induced EMT through downregulation of NF-\u03baB-Snail signaling in breast cancer cells. Oncol Rep. 29, 117\u2013124 (2013)","journal-title":"Oncol Rep."},{"key":"442_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.toxlet.2015.02.018","volume":"234","author":"P Zhang","year":"2015","unstructured":"P. Zhang, H. Bai, G. Liu, H. Wang, F. Chen, B. Zhang, P. Zeng, C. Wu, C. Peng, C. Huang, MicroRNA-33b, upregulated by EF24, a curcumin analog, suppresses the epithelial-to-mesenchymal transition (EMT) and migratory potential of melanoma cells by targeting HMGA2. Toxicol Lett. 234, 151\u2013161 (2015)","journal-title":"Toxicol Lett."},{"key":"442_CR26","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.3892\/ol.2015.4063","volume":"11","author":"HJ Hu","year":"2016","unstructured":"H.J. Hu, X.L. Lin, M.H. Liu, X.J. Fan, W.W. Zou, Curcumin mediates reversion of HGF-induced epithelial-mesenchymal transition via inhibition of c-Met expression in DU145 cells. Oncol Lett. 11, 1499\u20131505 (2016)","journal-title":"Oncol Lett."},{"key":"442_CR27","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.3892\/ijo.2015.3202","volume":"47","author":"Y Du","year":"2015","unstructured":"Y. Du, Q. Long, L. Zhang, Y. Shi, X. Liu, X. Li, B. Guan, Y. Tian, X. Wang, L. Li, Curcumin inhibits cancer-associated fibroblast-driven prostate cancer invasion through MAOA\/mTOR\/HIF-1\u03b1 signaling. Int J Oncol. 47, 2064\u20132072 (2015)","journal-title":"Int J Oncol."},{"key":"442_CR28","first-page":"4503","volume":"8","author":"Z Liang","year":"2015","unstructured":"Z. Liang, W. Xie, R. Wu, H. Geng, L. Zhao, C. Xie, X. Li, M. Zhu, W. Zhu, J. Zhu, Inhibition of tobacco smoke-induced bladder MAPK activation and epithelial-mesenchymal transition in mice by curcumin. Int J Clin Exp Pathol. 8, 4503 (2015)","journal-title":"Int J Clin Exp Pathol."},{"key":"442_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.yexcr.2016.01.006","volume":"341","author":"L Zhang","year":"2016","unstructured":"L. Zhang, X. Cheng, Y. Gao, C. Zhang, J. Bao, H. Guan, H. Yu, R. Lu, Q. Xu, Y. Sun, Curcumin inhibits metastasis in human papillary thyroid carcinoma BCPAP cells via down-regulation of the TGF-\u03b2\/Smad2\/3 signaling pathway. Exp Cell Res. 341, 157\u2013165 (2016)","journal-title":"Exp Cell Res."},{"key":"442_CR30","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s10529-013-1173-y","volume":"35","author":"C-Y Zhang","year":"2013","unstructured":"C.-Y. Zhang, L. Zhang, H.-X. Yu, J.-D. Bao, R.-R. Lu, Curcumin inhibits the metastasis of K1 papillary thyroid cancer cells via modulating E-cadherin and matrix metalloproteinase-9 expression. Biotechnol Lett. 35, 995\u20131000 (2013)","journal-title":"Biotechnol Lett."},{"key":"442_CR31","first-page":"2019","volume":"17","author":"Z Liang","year":"2018","unstructured":"Z. Liang, R. Wu, W. Xie, M. Zhu, C. Xie, X. Li, J. Zhu, W. Zhu, J. Wu, S. Geng, Curcumin reverses tobacco smoke-induced epithelial-mesenchymal transition by suppressing the MAPK pathway in the lungs of mice. Mol Med Rep. 17, 2019\u20132025 (2018)","journal-title":"Mol Med Rep."},{"key":"442_CR32","doi-asserted-by":"crossref","unstructured":"D. Jiao, J. Wang, W. Lu, X. Tang, J. Chen, H. Mou, Q.-y. Chen, Curcumin inhibited HGF-induced EMT and angiogenesis through regulating c-Met dependent PI3K\/Akt\/mTOR signaling pathways in lung cancer. Mol Ther Oncolytics. 3 (2016)","DOI":"10.1038\/mto.2016.18"},{"key":"442_CR33","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.4103\/0366-6999.156795","volume":"128","author":"J-H Xu","year":"2015","unstructured":"J.-H. Xu, H.-P. Yang, X.-D. Zhou, H.-J. Wang, L. Gong, C.-L. Tang, Role of Wnt inhibitory factor-1 in inhibition of bisdemethoxycurcumin mediated epithelial-to-mesenchymal transition in highly metastatic lung cancer 95D cells. Chin Med J. 128, 1376 (2015)","journal-title":"Chin Med J."},{"key":"442_CR34","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.4103\/ijmr.IJMR_1583_15","volume":"146","author":"S Shanmuganathan","year":"2017","unstructured":"S. Shanmuganathan, V.N. Sumantran, N. Angayarkanni, Epigallocatechin gallate & curcumin prevent transforming growth factor beta 1-induced epithelial to mesenchymal transition in ARPE-19 cells. Indian J Med Res. 146, S85 (2017)","journal-title":"Indian J Med Res."},{"key":"442_CR35","first-page":"7876064","volume":"2017","author":"S Xu","year":"2017","unstructured":"S. Xu, B. Jiang, H. Wang, C. Shen, H. Chen, L. Zeng, Curcumin suppresses intestinal fibrosis by inhibition of PPAR\u03b3-mediated epithelial-mesenchymal transition. Evid Based Complement Alternat Med. 2017, 7876064 (2017)","journal-title":"Evid Based Complement Alternat Med."},{"key":"442_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1248\/bpb.b16-00364","volume":"40","author":"F-q Zhu","year":"2017","unstructured":"F.-q. Zhu, M.-j. Chen, M. Zhu, R.-s. Zhao, W. Qiu, X. Xu, H. Liu, H.-w. Zhao, R.-j. Yu, X.-f. Wu, Curcumin suppresses epithelial\u2013mesenchymal transition of renal tubular epithelial cells through the inhibition of Akt\/mTOR Pathway. Biol Pharm Bull. 40, 17\u201324 (2017)","journal-title":"Biol Pharm Bull."},{"key":"442_CR37","doi-asserted-by":"publisher","first-page":"e58848","DOI":"10.1371\/journal.pone.0058848","volume":"8","author":"R Li","year":"2013","unstructured":"R. Li, Y. Wang, Y. Liu, Q. Chen, W. Fu, H. Wang, H. Cai, W. Peng, X. Zhang, Curcumin inhibits transforming growth factor-\u03b21-induced EMT via PPAR\u03b3 pathway, not Smad pathway in renal tubular epithelial cells. PloS one 8, e58848 (2013)","journal-title":"PloS one"},{"key":"442_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.drup.2010.07.001","volume":"13","author":"Z Wang","year":"2010","unstructured":"Z. Wang, Y. Li, A. Ahmad, A.S. Azmi, D. Kong, S. Banerjee, F.H. Sarkar, Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance. Drug Res Updates 13, 109\u2013118 (2010)","journal-title":"Drug Res Updates"},{"key":"442_CR39","doi-asserted-by":"crossref","unstructured":"Z. Wang, Y. Li, D. Kong, F.H. Sarkar, The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Current Drug Targets 11, 745\u2013751 (2010)","DOI":"10.2174\/138945010791170860"},{"key":"442_CR40","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"R. Kalluri, R.A. Weinberg, The basics of epithelial-mesenchymal transition. J Clin Invest. 119, 1420\u20131428 (2009)","journal-title":"J Clin Invest."},{"key":"442_CR41","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/onc.2010.215","volume":"29","author":"A Singh","year":"2010","unstructured":"A. Singh, J. Settleman, EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29, 4741 (2010)","journal-title":"Oncogene"},{"key":"442_CR42","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3747\/pdi.2014.00188","volume":"35","author":"Y Liu","year":"2015","unstructured":"Y. Liu, Z. Dong, H. Liu, J. Zhu, F. Liu, G. Chen, Transition of mesothelial cell to fibroblast in peritoneal dialysis: EMT, stem cell or bystander? Peritoneal Dialysis International 35, 14\u201325 (2015)","journal-title":"Peritoneal Dialysis International"},{"key":"442_CR43","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"J.P. Thiery, Epithelial\u2013mesenchymal transitions in tumour progression. Nature Rev Cancer 2, 442 (2002)","journal-title":"Nature Rev Cancer"},{"key":"442_CR44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s13402-018-0376-6","volume":"41","author":"M Yousefi","year":"2018","unstructured":"M. Yousefi, R. Nosrati, A. Salmaninejad, S. Dehghani, A. Shahryari, A. Saberi, Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis. Cell Oncol. 41, 123\u2013140 (2018)","journal-title":"Cell Oncol."},{"key":"442_CR45","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s13402-017-0345-5","volume":"40","author":"M Yousefi","year":"2017","unstructured":"M. Yousefi, T. Bahrami, A. Salmaninejad, R. Nosrati, P. Ghaffari, S.H. Ghaffari, Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options. Cell Oncol. 40, 419\u2013441 (2017)","journal-title":"Cell Oncol."},{"key":"442_CR46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrm1835","volume":"7","author":"JP Thiery","year":"2006","unstructured":"J.P. Thiery, J.P. Sleeman, Complex networks orchestrate epithelial\u2013mesenchymal transitions. Nat Rev Mol Cell Biol. 7, 131 (2006)","journal-title":"Nat Rev Mol Cell Biol."},{"key":"442_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.ASN.0000106015.29070.E7","volume":"15","author":"Y Liu","year":"2004","unstructured":"Y. Liu, Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol. 15, 1\u201312 (2004)","journal-title":"J Am Soc Nephrol"},{"key":"442_CR48","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/jcp.21223","volume":"213","author":"H Hugo","year":"2007","unstructured":"H. Hugo, M.L. Ackland, T. Blick, M.G. Lawrence, J.A. Clements, E.D. Williams, E.W. Thompson, Epithelial\u2014mesenchymal and mesenchymal\u2014epithelial transitions in carcinoma progression. J Cell Physiol. 213, 374\u2013383 (2007)","journal-title":"J Cell. Physiol."},{"key":"442_CR49","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ki.2009.222","volume":"76","author":"VH Haase","year":"2009","unstructured":"V.H. Haase, Oxygen regulates epithelial-to-mesenchymal transition: insights into molecular mechanisms and relevance to disease. Kidney Int. 76, 492\u2013499 (2009)","journal-title":"Kidney Int."},{"key":"442_CR50","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1083\/jcb.200601018","volume":"172","author":"JM Lee","year":"2006","unstructured":"J.M. Lee, S. Dedhar, R. Kalluri, E.W. Thompson, The epithelial\u2013mesenchymal transition: new insights in signaling, development, and disease. J Cell. Biol. 172, 973\u2013981 (2006)","journal-title":"J Cell. Biol."},{"key":"442_CR51","doi-asserted-by":"publisher","first-page":"714","DOI":"10.4161\/cbt.11.8.15274","volume":"11","author":"J Jiang","year":"2011","unstructured":"J. Jiang, Y.-l. Tang, X.-h. Liang, EMT: a new vision of hypoxia promoting cancer progression. Cancer Biol Ther. 11, 714\u2013723 (2011)","journal-title":"Cancer Biol. Ther."},{"key":"442_CR52","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nrc1694","volume":"5","author":"T Brabletz","year":"2005","unstructured":"T. Brabletz, A. Jung, S. Spaderna, F. Hlubek, T. Kirchner, Migrating cancer stem cells\u2014an integrated concept of malignant tumour progression. Nat Rev Cancer 5, 744 (2005)","journal-title":"Nat Rev Cancer"},{"key":"442_CR53","doi-asserted-by":"publisher","first-page":"7274","DOI":"10.1038\/sj.onc.1207947","volume":"23","author":"M Al-Hajj","year":"2004","unstructured":"M. Al-Hajj, M.F. Clarke, Self-renewal and solid tumor stem cells. Oncogene 23, 7274 (2004)","journal-title":"Oncogene"},{"key":"442_CR54","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1158\/0008-5472.CAN-07-2559","volume":"68","author":"TR Graham","year":"2008","unstructured":"T.R. Graham, H.E. Zhau, V.A. Odero-Marah, A.O. Osunkoya, K.S. Kimbro, M. Tighiouart, T. Liu, J.W. Simons, R.M. O'Regan, Insulin-like growth factor-I\u2013dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res. 68, 2479\u20132488 (2008)","journal-title":"Cancer Res."},{"key":"442_CR55","doi-asserted-by":"crossref","unstructured":"C. Scheel and R.A. Weinberg, in Seminars in cancer biology, (Elsevier, 2012), p. 396-403","DOI":"10.1016\/j.semcancer.2012.04.001"},{"key":"442_CR56","unstructured":"A.J. Armstrong, M.S. Marengo, S. Oltean, G. Kemeny, R. Bitting, J. Turnbull, C.I. Herold, P.K. Marcom, D. George and M. Garcia-Blanco, Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res. 9, 997\u20131007 (2011)"},{"key":"442_CR57","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s13402-018-0386-4","volume":"41","author":"W Wang","year":"2018","unstructured":"W. Wang, L. Wan, S. Wu, J. Yang, Y. Zhou, F. Liu, Z. Wu, Y. Cheng, Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis. Cell Oncol. 41, 495\u2013504 (2018)","journal-title":"Cell Oncol."},{"key":"442_CR58","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1158\/1541-7786.MCR-12-0274","volume":"10","author":"G Horst van der","year":"2012","unstructured":"G. van der Horst, L. Bos, G. van der Pluijm, Epithelial plasticity, cancer stem cells and the tumor supportive stroma in bladder carcinoma. Mol Cancer Res. 10, 995\u20131009 (2012)","journal-title":"Mol Cancer Res."},{"key":"442_CR59","doi-asserted-by":"crossref","unstructured":"I. Malanchi, Tumour cells coerce host tissue to cancer spread. Bonekey Rep. 2, 371 (2013)","DOI":"10.1038\/bonekey.2013.105"},{"key":"442_CR60","doi-asserted-by":"publisher","unstructured":"F. Amerizadeh, A. Bahrami, M. Khazaei, A. Hesari, M. Rezayi, S. Talebian, M. Maftouh, M. Moetamani-Ahmadi, S. Seifi, S. ShahidSales, M. Joudi-Mashhad, G.A. Ferns, F. Ghasemi, A. Avan, Current status and future prospects of transforming growth factor-\u03b2 as a potential prognostic and therapeutictarget in the treatment of breast cancer. J Cell Biochem. (2019). https:\/\/doi.org\/10.1002\/jcb.27831","DOI":"10.1002\/jcb.27831"},{"key":"442_CR61","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/sj.emboj.7600069","volume":"23","author":"J Zavadil","year":"2004","unstructured":"J. Zavadil, L. Cermak, N. Soto-Nieves, E.P. B\u00f6ttinger, Integration of TGF-\u03b2\/Smad and Jagged1\/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 23, 1155\u20131165 (2004)","journal-title":"EMBO J."},{"key":"442_CR62","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2853","volume":"10","author":"H Ikushima","year":"2010","unstructured":"H. Ikushima, K. Miyazono, TGF\u03b2 signalling: a complex web in cancer progression. Nature Rev Cancer 10, 415 (2010)","journal-title":"Nature Rev Cancer"},{"key":"442_CR63","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ceb.2005.08.001","volume":"17","author":"MA Huber","year":"2005","unstructured":"M.A. Huber, N. Kraut, H. Beug, Molecular requirements for epithelial\u2013mesenchymal transition during tumor progression. Curr Opin Cell Biol. 17, 548\u2013558 (2005)","journal-title":"Curr Opin Cell Biol."},{"key":"442_CR64","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"S.A. Mani, W. Guo, M.-J. Liao, E.N. Eaton, A. Ayyanan, A.Y. Zhou, M. Brooks, F. Reinhard, C.C. Zhang, M. Shipitsin, The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704\u2013715 (2008)","journal-title":"Cell"},{"key":"442_CR65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1165\/rcmb.2013-0314TR","volume":"50","author":"ME Kidd","year":"2014","unstructured":"M.E. Kidd, D.K. Shumaker, K.M. Ridge, The role of vimentin intermediate filaments in the progression of lung cancer. Am J Respir Cell Mol Biol. 50, 1\u20136 (2014)","journal-title":"Am J Respir Cell Mol Biol."},{"key":"442_CR66","doi-asserted-by":"publisher","first-page":"8319","DOI":"10.1158\/0008-5472.CAN-06-0410","volume":"66","author":"JJ Christiansen","year":"2006","unstructured":"J.J. Christiansen, A.K. Rajasekaran, Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 66, 8319\u20138326 (2006)","journal-title":"Cancer Res."},{"key":"442_CR67","doi-asserted-by":"publisher","first-page":"20489","DOI":"10.1074\/jbc.274.29.20489","volume":"274","author":"K Verschueren","year":"1999","unstructured":"K. Verschueren, J.E. Remacle, C. Collart, H. Kraft, B.S. Baker, P. Tylzanowski, L. Nelles, G. Wuytens, M.-T. Su, R. Bodmer, SIP1, a novel zinc finger\/homeodomain repressor, interacts with Smad proteins and binds to 5\u2032-CACCT sequences in candidate target genes. J Biol Chem. 274, 20489\u201320498 (1999)","journal-title":"J Biol Chem."},{"key":"442_CR68","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/carcin\/bgs005","volume":"33","author":"E-H Nam","year":"2012","unstructured":"E.-H. Nam, Y. Lee, Y.-K. Park, J.W. Lee, S. Kim, ZEB2 upregulates integrin \u03b15 expression through cooperation with Sp1 to induce invasion during epithelial\u2013mesenchymal transition of human cancer cells. Carcinogenesis 33, 563\u2013571 (2012)","journal-title":"Carcinogenesis"},{"key":"442_CR69","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ccr.2011.01.036","volume":"19","author":"MA Eckert","year":"2011","unstructured":"M.A. Eckert, T.M. Lwin, A.T. Chang, J. Kim, E. Danis, L. Ohno-Machado, J. Yang, Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell 19, 372\u2013386 (2011)","journal-title":"Cancer Cell"},{"key":"442_CR70","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1158\/0008-5472.CAN-10-2330","volume":"71","author":"E Casas","year":"2011","unstructured":"E. Casas, J. Kim, A. Bendesky, L. Ohno-Machado, C.J. Wolfe, J. Yang, Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. Cancer Res. 71, 245\u2013254 (2011)","journal-title":"Cancer Res."},{"key":"442_CR71","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1242\/dev.01907","volume":"132","author":"A Barrallo-Gimeno","year":"2005","unstructured":"A. Barrallo-Gimeno, M.A. Nieto, The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 132, 3151\u20133161 (2005)","journal-title":"Development"},{"key":"442_CR72","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1002\/jcp.26212","volume":"233","author":"M Mohajeri","year":"2018","unstructured":"M. Mohajeri, B. Behnam, A.F. Cicero, A. Sahebkar, Protective effects of curcumin against aflatoxicosis: A comprehensive review. J Cell Physiol. 233, 3552\u20133577 (2018)","journal-title":"J Cell Physiol."},{"key":"442_CR73","unstructured":"A.B. Kunnumakkara, C. Koca, S. Dey, P. Gehlot, S. Yodkeeree, D. Danda, B. Sung, B.B. Aggarwal, Molecular targets and therapeutic uses of spices: modern uses for ancient medicine. World Scientific 57, 1510\u20131528 (2009)"},{"key":"442_CR74","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.phrs.2016.03.026","volume":"107","author":"A Sahebkar","year":"2016","unstructured":"A. Sahebkar, A.F.G. Cicero, L.E. Simental-Mend\u00eda, B.B. Aggarwal, S.C. Gupta, Curcumin downregulates human tumor necrosis factor-\u03b1 levels: A systematic review and meta-analysis ofrandomized controlled trials. Pharmacol Res. 107, 234\u2013242 (2016)","journal-title":"Pharmacol Res."},{"key":"442_CR75","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.clnu.2014.12.019","volume":"34","author":"Y Panahi","year":"2015","unstructured":"Y. Panahi, M.S. Hosseini, N. Khalili, E. Naimi, M. Majeed, A. Sahebkar, Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis. Clin Nutr. 34, 1101\u20131108 (2015)","journal-title":"Clin Nutr."},{"key":"442_CR76","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/jcp.25778","volume":"233","author":"E Abdollahi","year":"2018","unstructured":"E. Abdollahi, A.A. Momtazi, T.P. Johnston, A. Sahebkar, Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades? J Cell Physiol. 233, 830\u2013848 (2018)","journal-title":"J Cell Physiol"},{"key":"442_CR77","doi-asserted-by":"publisher","first-page":"965","DOI":"10.5114\/aoms.2017.69326","volume":"13","author":"AFG Cicero","year":"2017","unstructured":"A.F.G. Cicero, A. Colletti, G. Bajraktari, O. Descamps, D.M. Djuric, M. Ezhov, Z. Fras, N. Katsiki, M. Langlois, G. Latkovskis, D.B. Panagiotakos, G. Paragh, D.P. Mikhailidis, O. Mitchenko, B. Paulweber, D. Pella, C. Pitsavos, \u017d. Reiner, K.K. Ray, M. Rizzo, A. Sahebkar, M.C. Serban, L.S. Sperling, P.P. Toth, D. Vinereanu, M. Vrabl\u00edk, N.D. Wong, M. Banach, Lipid lowering nutraceuticals in clinical practice: Position paper from an International Lipid Expert Panel. Arch Med Sci. 13, 965\u20131005 (2017)","journal-title":"Arch Med Sci"},{"key":"442_CR78","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.nut.2016.03.018","volume":"32","author":"Y Panahi","year":"2016","unstructured":"Y. Panahi, M.S. Hosseini, N. Khalili, E. Naimi, S.S. Soflaei, M. Majeed, A. Sahebkar, Effects of supplementation with curcumin on serum adipokine concentrations: A randomized controlled trial. Nutrition 32, 1116\u20131122 (2016)","journal-title":"Nutrition"},{"key":"442_CR79","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.phrs.2017.02.008","volume":"119","author":"S Ganjali","year":"2017","unstructured":"S. Ganjali, C.N. Blesso, M. Banach, M. Pirro, M. Majeed, A. Sahebkar, Effects of curcumin on HDL functionality. Pharmacol Res. 119, 208\u2013218 (2017)","journal-title":"Pharmacol Res."},{"key":"442_CR80","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.1002\/jcp.26249","volume":"233","author":"F Keihanian","year":"2018","unstructured":"F. Keihanian, A. Saeidinia, R.K. Bagheri, T.P. Johnston, A. Sahebkar, Curcumin, hemostasis, thrombosis, and coagulation. J Cell Physiol. 233, 4497\u20134511 (2018)","journal-title":"J Cell Physiol."},{"key":"442_CR81","doi-asserted-by":"publisher","first-page":"8713","DOI":"10.1002\/jcb.27192","volume":"119","author":"J Tabeshpour","year":"2018","unstructured":"J. Tabeshpour, M. Hashemzaei, A. Sahebkar, The regulatory role of curcumin on platelet functions. J Cell Biochem. 119, 8713\u20138722 (2018)","journal-title":"J Cell Biochem."},{"key":"442_CR82","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1055\/s-0044-101752","volume":"68","author":"Y Panahi","year":"2018","unstructured":"Y. Panahi, N. Khalili, E. Sahebi, S. Namazi, L.E. Simental-Mend\u00eda, M. Majeed, A. Sahebkar, Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with Type 2 diabetes mellitus: A randomized double-blind placebo-controlled trial. Drug Res. 68, 403\u2013409 (2018)","journal-title":"Drug Res."},{"key":"442_CR83","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.jff.2015.01.005","volume":"18","author":"A Sahebkar","year":"2015","unstructured":"A. Sahebkar, M.C. Serban, S. Ursoniu, M. Banach, Effect of curcuminoids on oxidative stress: A systematic review and meta-analysis of randomized controlled trials. J Funct Foods 18, 898\u2013909 (2015)","journal-title":"J Funct Foods."},{"key":"442_CR84","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10787-016-0301-4","volume":"25","author":"Y Panahi","year":"2017","unstructured":"Y. Panahi, N. Khalili, E. Sahebi, S. Namazi, M.S. Karimian, M. Majeed, A. Sahebkar, Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial. Inflammopharmacology 25, 25\u201331 (2017)","journal-title":"Inflammopharmacology"},{"key":"442_CR85","first-page":"1192","volume":"17","author":"A Sahebkar","year":"2016","unstructured":"A. Sahebkar, Y. Henrotin, Analgesic efficacy and safety of curcuminoids in clinical practice: A systematic review and meta-analysis of randomized controlled trials. Pain Med. (United States) 17, 1192\u20131202 (2016)","journal-title":"Pain Med. (United States)"},{"key":"442_CR86","doi-asserted-by":"publisher","first-page":"969","DOI":"10.2174\/1381612822666161010115235","volume":"23","author":"NA Zabihi","year":"2017","unstructured":"N.A. Zabihi, M. Pirro, T.P. Johnston, A. Sahebkar, Is there a role for curcumin supplementation in the treatment of non-alcoholic fatty liver disease? The data suggest yes. Curr Pharm Des. 23, 969\u2013982 (2017)","journal-title":"Curr Pharm Des"},{"key":"442_CR87","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1055\/s-0043-100019","volume":"67","author":"Y Panahi","year":"2017","unstructured":"Y. Panahi, P. Kianpour, R. Mohtashami, R. Jafari, L.E. Simental-Mend\u00eda, A. Sahebkar, Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial. Drug Res. 67, 244\u2013251 (2017)","journal-title":"Drug Res."},{"key":"442_CR88","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1002\/ijc.30224","volume":"139","author":"H Mirzaei","year":"2016","unstructured":"H. Mirzaei, G. Naseri, R. Rezaee, M. Mohammadi, Z. Banikazemi, H.R. Mirzaei, H. Salehi, M. Peyvandi, J.M. Pawelek, A. Sahebkar, Curcumin: A new candidate for melanoma therapy? Int J Cancer. 139, 1683\u20131695 (2016)","journal-title":"Int J Cancer."},{"key":"442_CR89","unstructured":"A.A. Momtazi, F. Shahabipour, S. Khatibi, T.P. Johnston, M. Pirro and A. Sahebkar. Curcumin as a MicroRNA regulator in cancer: A review. Rev Physiol Biochem Pharmacol. 171, 1\u201338 (2016)"},{"key":"442_CR90","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/CEJ.0b013e32832c389e","volume":"18","author":"M Iranshahi","year":"2009","unstructured":"M. Iranshahi, A. Sahebkar, M. Takasaki, T. Konoshima, H. Tokuda, Cancer chemopreventive activity of the prenylated coumarin, umbelliprenin, in vivo. Eur J Cancer Prev. 18, 412\u2013415 (2009)","journal-title":"Eur J Cancer Prev."},{"key":"442_CR91","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.2174\/1381612822666160527113501","volume":"22","author":"AA Momtazi","year":"2016","unstructured":"A.A. Momtazi, A. Sahebkar, Difluorinated curcumin: A promising curcumin analogue with improved anti-tumor activity and pharmacokinetic profile. Curr Pharm Des. 22, 4386\u20134397 (2016)","journal-title":"Curr Pharm Des."},{"key":"442_CR92","unstructured":"A. Soltani, A. Salmaninejad, M. Jalili-Nik, A. Soleimani, H. Javid, S.I. Hashemy, A. Sahebkar, 5\u2032-Adenosine monophosphate-activated protein kinase: A potential target for disease prevention by curcumin. J Cell Physiol. 234, 2241\u20132251 (2019)"},{"key":"442_CR93","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1002\/jcp.26538","volume":"233","author":"RM Marjaneh","year":"2018","unstructured":"R.M. Marjaneh, F. Rahmani, S.M. Hassanian, N. Rezaei, M. Hashemzehi, A. Bahrami, F. Ariakia, H. Fiuji, A. Sahebkar, A. Avan, Phytosomal curcumin inhibits tumor growth in colitis-associated colorectal cancer. J Cell Physiol. 233, 6785\u20136798 (2018)","journal-title":"J Cell Physiol"},{"key":"442_CR94","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.phrs.2016.11.017","volume":"115","author":"D Lelli","year":"2017","unstructured":"D. Lelli, A. Sahebkar, T.P. Johnston, C. Pedone, Curcumin use in pulmonary diseases: State of the art and future perspectives. Pharmacol Res. 115, 133\u2013148 (2017). https:\/\/doi.org\/10.1016\/j.phrs.2016.11.017","journal-title":"Pharmacol Res."},{"key":"442_CR95","unstructured":"L. Wang, B. Zhang, F. Huang, B. Liu, Y. Xie, Curcumin inhibits lipolysis via suppression of endoplasmic reticulum stress in adipose tissue and prevents hepatic insulin resistance. J Lipid Res. 57, 1243\u20131255 (2016)"},{"key":"442_CR96","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.phrs.2018.09.012","volume":"136","author":"N Parsamanesh","year":"2018","unstructured":"N. Parsamanesh, M. Moossavi, A. Bahrami, A.E. Butler, A. Sahebkar, Therapeutic potential of curcumin in diabetic complications. Pharmacol Res. 136, 181\u2013193 (2018)","journal-title":"Pharmacol Res."},{"key":"442_CR97","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1254\/jphs.14173FP","volume":"126","author":"X Zhou","year":"2014","unstructured":"X. Zhou, J. Zhang, C. Xu, W. Wang, Curcumin ameliorates renal fibrosis by inhibiting local fibroblast proliferation and extracellular matrix deposition. J Pharmacol Sci. 126, 344\u2013350 (2014)","journal-title":"J Pharmacol Sci."},{"key":"442_CR98","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.taap.2016.05.011","volume":"304","author":"L Ding","year":"2016","unstructured":"L. Ding, J. Li, B. Song, X. Xiao, B. Zhang, M. Qi, W. Huang, L. Yang, Z. Wang, Curcumin rescues high fat diet-induced obesity and insulin sensitivity in mice through regulating SREBP pathway. Toxicol Appl Pharmacol. 304, 99\u2013109 (2016)","journal-title":"Toxicol Appl Pharmacol."},{"key":"442_CR99","unstructured":"N. Barati, A.A. Momtazi-Borojeni, M. Majeed, A. Sahebkar, Potential therapeutic effects of curcumin in gastric cancer. J Cell Physiol. 234, 2317\u20132328 (2019)"},{"key":"442_CR100","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2174\/1570161116666180209113014","volume":"17","author":"A Shakeri","year":"2019","unstructured":"A. Shakeri, N. Ward, Y. Panahi, A. Sahebkar, Anti-angiogenic activity of curcumin in cancer therapy: a narrative review. Curr Vasc Pharmacol. 17, 262\u2013269 (2019)","journal-title":"Curr Vasc Pharmacol"},{"key":"442_CR101","unstructured":"M. Hashemzehi, R. Behnam-Rassouli, S.M. Hassanian, M. Moradi-Binabaj, R. Moradi-Marjaneh, F. Rahmani, H. Fiuji, M. Jamili, M. Mirahmadi, N. Boromand, Phytosomal-curcumin antagonizes cell growth and migration, induced by thrombin through AMP-Kinase in breast cancer. J Cell Biochem. 119, 5996\u20136007 (2018)"},{"key":"442_CR102","unstructured":"L. Hamzehzadeh, S.L. Atkin, M. Majeed, A.E. Butler, A. Sahebkar, The versatile role of curcumin in cancer prevention and treatment: A focus on PI3K\/AKT pathway. J Cell Physiol. 233, 6530\u20136537 (2018)"},{"key":"442_CR103","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.3390\/molecules20022728","volume":"20","author":"M Shanmugam","year":"2015","unstructured":"M. Shanmugam, G. Rane, M. Kanchi, F. Arfuso, A. Chinnathambi, M. Zayed, S. Alharbi, B. Tan, A. Kumar, G. Sethi, The multifaceted role of curcumin in cancer prevention and treatment. Molecules 20, 2728\u20132769 (2015)","journal-title":"Molecules"},{"key":"442_CR104","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/nutrit\/nuu064","volume":"73","author":"JG Devassy","year":"2015","unstructured":"J.G. Devassy, I.D. Nwachukwu, P.J. Jones, Curcumin and cancer: barriers to obtaining a health claim. Nutr Rev. 73, 155\u2013165 (2015)","journal-title":"Nutr Rev."},{"key":"442_CR105","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/ardp.200900319","volume":"343","author":"A Shehzad","year":"2010","unstructured":"A. Shehzad, F. Wahid, Y.S. Lee, Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Archiv der Pharmazie 343, 489\u2013499 (2010)","journal-title":"Archiv der Pharmazie"},{"key":"442_CR106","doi-asserted-by":"publisher","first-page":"89369","DOI":"10.1155\/2007\/89369","volume":"2007","author":"A Jacob","year":"2007","unstructured":"A. Jacob, R. Wu, M. Zhou, P. Wang, Mechanism of the anti-inflammatory effect of curcumin: PPAR-\u03b3 activation. PPAR Res. 2007, 89369 (2007)","journal-title":"PPAR Res."},{"key":"442_CR107","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1158\/0008-5472.CAN-07-5222","volume":"68","author":"BH Choi","year":"2008","unstructured":"B.H. Choi, C.G. Kim, Y.-S. Bae, Y. Lim, Y.H. Lee, S.Y. Shin, p21Waf1\/Cip1 expression by curcumin in U-87MG human glioma cells: role of early growth response-1 expression. Cancer Res. 68, 1369\u20131377 (2008)","journal-title":"Cancer Res."},{"key":"442_CR108","doi-asserted-by":"publisher","first-page":"337","DOI":"10.5483\/BMBRep.2002.35.3.337","volume":"35","author":"S-S Han","year":"2002","unstructured":"S.-S. Han, Y.-S. Keum, H.-J. Seo, Y.-J. Surh, Curcumin suppresses activation of NF-\u03baB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. BMB Rep. 35, 337\u2013342 (2002)","journal-title":"BMB Rep."},{"key":"442_CR109","doi-asserted-by":"publisher","DOI":"10.1208\/aapsj080352","volume":"8","author":"RL Thangapazham","year":"2006","unstructured":"R.L. Thangapazham, A. Sharma, R.K. Maheshwari, Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J. 8, E443 (2006)","journal-title":"AAPS J."},{"key":"442_CR110","unstructured":"S.S. Bhandarkar and J.L. Arbiser, in The molecular targets and therapeutic uses of curcumin in health and disease. (Springer, 2007), p. 185-195"},{"key":"442_CR111","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0006-2952(02)01517-4","volume":"65","author":"MS Squires","year":"2003","unstructured":"M.S. Squires, E.A. Hudson, L. Howells, S. Sale, C.E. Houghton, J.L. Jones, L.H. Fox, M. Dickens, S.A. Prigent, M.M. Manson, Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase\/protein kinase B (PI3K\/PKB) pathways to induction of apoptosis by curcumin in breast cells. Biochem Pharmacol. 65, 361\u2013376 (2003)","journal-title":"Biochem Pharmacol."},{"key":"442_CR112","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.canlet.2009.06.023","volume":"288","author":"JH Seo","year":"2010","unstructured":"J.H. Seo, K.J. Jeong, W.J. Oh, H.J. Sul, J.S. Sohn, Y.K. Kim, J.K. Kang, C.G. Park, H.Y. Lee, Lysophosphatidic acid induces STAT3 phosphorylation and ovarian cancer cell motility: their inhibition by curcumin. Cancer Lett. 288, 50\u201356 (2010)","journal-title":"Cancer Lett."},{"key":"442_CR113","doi-asserted-by":"publisher","first-page":"e55934","DOI":"10.1371\/journal.pone.0055934","volume":"8","author":"J Yu","year":"2013","unstructured":"J. Yu, Y. Peng, L.-C. Wu, Z. Xie, Y. Deng, T. Hughes, S. He, X. Mo, M. Chiu, Q.-E. Wang, Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia. PloS one 8, e55934 (2013)","journal-title":"PloS one"},{"key":"442_CR114","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/carcin\/23.1.143","volume":"23","author":"RJ Anto","year":"2002","unstructured":"R.J. Anto, A. Mukhopadhyay, K. Denning, B.B. Aggarwal, Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis 23, 143\u2013150 (2002)","journal-title":"Carcinogenesis"},{"key":"442_CR115","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.fct.2006.07.027","volume":"45","author":"R Hayeshi","year":"2007","unstructured":"R. Hayeshi, I. Mutingwende, W. Mavengere, V. Masiyanise, S. Mukanganyama, The inhibition of human glutathione S-transferases activity by plant polyphenolic compounds ellagic acid and curcumin. Food Chem Toxicol. 45, 286\u2013295 (2007)","journal-title":"Food Chem Toxicol."},{"key":"442_CR116","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0006-2952(95)02113-2","volume":"51","author":"S Oetari","year":"1996","unstructured":"S. Oetari, M. Sudibyo, J.N. Commandeur, R. Samhoedi, N.P. Vermeulen, Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver. Biochem Pharmacol. 51, 39\u201345 (1996)","journal-title":"Biochem Pharmacol."},{"key":"442_CR117","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0278-6915(00)00165-4","volume":"39","author":"R Thapliyal","year":"2001","unstructured":"R. Thapliyal, G. Maru, Inhibition of cytochrome P450 isozymes by curcumins in vitro and in vivo. Food Chem Toxicol. 39, 541\u2013547 (2001)","journal-title":"Food Chem Toxicol."},{"key":"442_CR118","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0304-3835(95)03827-J","volume":"94","author":"AJ Ruby","year":"1995","unstructured":"A.J. Ruby, G. Kuttan, K.D. Babu, K. Rajasekharan, R. Kuttan, Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett. 94, 79\u201383 (1995)","journal-title":"Cancer Lett."},{"key":"442_CR119","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.1038\/sj.onc.1202980","volume":"18","author":"SM Plummer","year":"1999","unstructured":"S.M. Plummer, K.A. Holloway, M.M. Manson, R.J. Munks, A. Kaptein, S. Farrow, L. Howells, Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-\u03baB activation via the NIK\/IKK signalling complex. Oncogene 18, 6013 (1999)","journal-title":"Oncogene"},{"key":"442_CR120","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0891-5849(00)00294-X","volume":"28","author":"R Motterlini","year":"2000","unstructured":"R. Motterlini, R. Foresti, R. Bassi, C.J. Green, Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med. 28, 1303\u20131312 (2000)","journal-title":"Free Radic Biol Med."},{"key":"442_CR121","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cbi.2008.05.003","volume":"174","author":"T Ak","year":"2008","unstructured":"T. Ak, \u0130. G\u00fcl\u00e7in, Antioxidant and radical scavenging properties of curcumin. Chem Biol Interact. 174, 27\u201337 (2008)","journal-title":"Chem Biol Interact."},{"key":"442_CR122","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0006-291X(02)00633-2","volume":"295","author":"KC Das","year":"2002","unstructured":"K.C. Das, C.K. Das, Curcumin (diferuloylmethane), a singlet oxygen (1O2) quencher. Biochem Biophys Res Commun. 295, 62\u201366 (2002)","journal-title":"Biochem Biophys Res Commun."},{"key":"442_CR123","doi-asserted-by":"publisher","first-page":"e26012","DOI":"10.1371\/journal.pone.0026012","volume":"6","author":"A Barzegar","year":"2011","unstructured":"A. Barzegar, A.A. Moosavi-Movahedi, Intracellular ROS protection efficiency and free radical-scavenging activity of curcumin. PLoS One 6, e26012 (2011)","journal-title":"PLoS One"},{"key":"442_CR124","first-page":"1133","volume":"29","author":"T Onoue","year":"2006","unstructured":"T. Onoue, D. Uchida, N.M. Begum, Y. Tomizuka, H. Yoshida, M. Sato, Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1\/CXCR4 system in oral squamous cell carcinoma cells. Int J Oncol. 29, 1133\u20131138 (2006)","journal-title":"Int J Oncol."},{"key":"442_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcms.2006.11.004","volume":"35","author":"SW Pyo","year":"2007","unstructured":"S.W. Pyo, M. Hashimoto, Y.S. Kim, C.H. Kim, S.H. Lee, K.R. Johnson, M.J. Wheelock, J.U. Park, Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome. J Craniomaxillofac Surg. 35, 1\u20139 (2007)","journal-title":"J Craniomaxillofac Surg"},{"key":"442_CR126","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s00432-013-1499-9","volume":"139","author":"C-C Fan","year":"2013","unstructured":"C.-C. Fan, T.-Y. Wang, Y.-A. Cheng, S.S. Jiang, C.-W. Cheng, A.Y.-L. Lee, T.-Y. Kao, Expression of E-cadherin, Twist, and p53 and their prognostic value in patients with oral squamous cell carcinoma. J Cancer Res Clin Oncol. 139, 1735\u20131744 (2013)","journal-title":"J Cancer Res Clin Oncol."},{"key":"442_CR127","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1158\/0008-5472.CAN-08-2023","volume":"69","author":"NA Dallas","year":"2009","unstructured":"N.A. Dallas, L. Xia, F. Fan, M.J. Gray, P. Gaur, G. Van Buren, S. Samuel, M.P. Kim, S.J. Lim, L.M. Ellis, Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res. 69, 1951\u20131957 (2009)","journal-title":"Cancer Res."},{"key":"442_CR128","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nature15748","volume":"527","author":"KR Fischer","year":"2015","unstructured":"K.R. Fischer, A. Durrans, S. Lee, J. Sheng, F. Li, S.T. Wong, H. Choi, T. El Rayes, S. Ryu, J. Troeger, Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 527, 472 (2015)","journal-title":"Nature"},{"key":"442_CR129","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/CAD.0000000000000599","volume":"29","author":"C Zhang","year":"2018","unstructured":"C. Zhang, Y. Xu, H. Wang, G. Li, H. Yan, Z. Fei, Y. Xu, W. Li, Curcumin reverses irinotecan resistance in colon cancer cell by regulation of epithelial\u2013mesenchymal transition. Anticancer Drugs 29, 334\u2013340 (2018)","journal-title":"Anticancer Drugs"},{"key":"442_CR130","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/carcin\/bgv006","volume":"36","author":"S Toden","year":"2015","unstructured":"S. Toden, Y. Okugawa, T. Jascur, D. Wodarz, N.L. Komarova, C. Buhrmann, M. Shakibaei, C.R. Boland, A. Goel, Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer. Carcinogenesis 36, 355\u2013367 (2015)","journal-title":"Carcinogenesis"},{"key":"442_CR131","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/1465-9921-12-154","volume":"12","author":"D Zhang","year":"2011","unstructured":"D. Zhang, C. Huang, C. Yang, R.J. Liu, J. Wang, J. Niu, D. Br\u00f6mme, Antifibrotic effects of curcumin are associated with overexpression of cathepsins K and L in bleomycin treated mice and human fibroblasts. Respir Res. 12, 154 (2011)","journal-title":"Respir Res."},{"key":"442_CR132","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1002\/jcp.26041","volume":"233","author":"A Bahrami","year":"2018","unstructured":"A. Bahrami, M. Khazaei, S.M. Hassanian, S. ShahidSales, M. Joudi-Mashhad, M. Maftouh, M.H. Jazayeri, M.R. Parizade, G.A. Ferns, A. Avan, Targeting the tumor microenvironment as a potential therapeutic approach in colorectal cancer: Rational and progress. J Cell Physiol. 233, 2928\u20132936 (2018)","journal-title":"J Cell Physiol"},{"key":"442_CR133","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1002\/jcp.25798","volume":"232","author":"A Bahrami","year":"2017","unstructured":"A. Bahrami, M. Khazaei, F. Bagherieh, M. Ghayour-Mobarhan, M. Maftouh, S.M. Hassanian, A. Avan, Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies. J Cell Physiol. 232, 2931\u20132937 (2017)","journal-title":"J Cell Physiol."},{"key":"442_CR134","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s13402-018-0388-2","volume":"41","author":"P Nilendu","year":"2018","unstructured":"P. Nilendu, S.C. Sarode, D. Jahagirdar, I. Tandon, S. Patil, G.S. Sarode, J.K. Pal, N.K. Sharma, Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistance. Cell Oncol. 41, 353\u2013367 (2018)","journal-title":"Cell Oncol."},{"key":"442_CR135","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s13402-018-0371-y","volume":"41","author":"N Eiro","year":"2018","unstructured":"N. Eiro, L. Gonzalez, A. Martinez-Ordonez, B. Fernandez-Garcia, L.O. Gonzalez, S. Cid, F. Dominguez, R. Perez-Fernandez, F.J. Vizoso, Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis. Cell Oncol. 41, 369\u2013378 (2018)","journal-title":"Cell Oncol."},{"key":"442_CR136","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s13402-017-0344-6","volume":"40","author":"MM Koczorowska","year":"2017","unstructured":"M.M. Koczorowska, C. Friedemann, K. Geiger, M. Follo, M.L. Biniossek, O. Schilling, Differential effect of TGFbeta on the proteome of cancer associated fibroblasts and cancer epithelial cells in a co-culture approach - a short report. Cell Oncol. 40, 639\u2013650 (2017)","journal-title":"Cell Oncol."},{"key":"442_CR137","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jcb.26183","volume":"119","author":"A Bahrami","year":"2018","unstructured":"A. Bahrami, S.M. Hassanian, M. Khazaei, M. Hasanzadeh, S. Shahidsales, M. Maftouh, G.A. Ferns, A. Avan, The therapeutic potential of targeting tumor microenvironment in breast cancer: Rational strategies and recent progress. J Cell Biochem. 119, 111\u2013122 (2018)","journal-title":"J Cell Biochem."},{"key":"442_CR138","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/ijc.25358","volume":"127","author":"M Vered","year":"2010","unstructured":"M. Vered, D. Dayan, R. Yahalom, A. Dobriyan, I. Barshack, I.O. Bello, S. Kantola, T. Salo, Cancer-associated fibroblasts and epithelial-mesenchymal transition in metastatic oral tongue squamous cell carcinoma. Int J Cancer 127, 1356\u20131362 (2010)","journal-title":"Int J Cancer"},{"key":"442_CR139","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/2045-3701-1-29","volume":"1","author":"Y Jing","year":"2011","unstructured":"Y. Jing, Z. Han, S. Zhang, Y. Liu, L. Wei, Epithelial-Mesenchymal Transition in tumor microenvironment. Cell & Bioscience 1, 29 (2011)","journal-title":"Cell & Bioscience"},{"key":"442_CR140","doi-asserted-by":"publisher","first-page":"e107514","DOI":"10.1371\/journal.pone.0107514","volume":"9","author":"C Buhrmann","year":"2014","unstructured":"C. Buhrmann, P. Kraehe, C. Lueders, P. Shayan, A. Goel, M. Shakibaei, Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMT. PLoS One 9, e107514 (2014)","journal-title":"PLoS One"},{"key":"442_CR141","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/carcin\/bgq280","volume":"32","author":"FC Kelleher","year":"2010","unstructured":"F.C. Kelleher, Hedgehog signaling and therapeutics in pancreatic cancer. Carcinogenesis 32, 445\u2013451 (2010)","journal-title":"Carcinogenesis"},{"key":"442_CR142","doi-asserted-by":"publisher","first-page":"873","DOI":"10.2174\/156652409789105570","volume":"9","author":"Y Katoh","year":"2009","unstructured":"Y. Katoh, M. Katoh, Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Curr Mol Med. 9, 873\u2013886 (2009)","journal-title":"Curr Mol Med."},{"key":"442_CR143","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.3892\/or.2016.4709","volume":"35","author":"L Cao","year":"2016","unstructured":"L. Cao, X. Xiao, J. Lei, W. Duan, Q. Ma, W. Li, Curcumin inhibits hypoxia-induced epithelial-mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway. Oncol Rep. 35, 3728\u20133734 (2016)","journal-title":"Oncol Rep."},{"key":"442_CR144","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/MPA.0b013e3181f7e09f","volume":"40","author":"J Dai","year":"2011","unstructured":"J. Dai, K. Ai, Y. Du, G. Chen, Sonic hedgehog expression correlates with distant metastasis in pancreatic adenocarcinoma. Pancreas 40, 233\u2013236 (2011)","journal-title":"Pancreas"},{"key":"442_CR145","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.phrs.2018.10.009","volume":"137","author":"A Bahrami","year":"2018","unstructured":"A. Bahrami, S.L. Atkin, M. Majeed, A. Sahebkar, Effects of curcumin on hypoxia-inducible factor as a new therapeutic target. Pharmacol Res. 137, 159\u2013169 (2018)","journal-title":"Pharmacol Res."},{"key":"442_CR146","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.lungcan.2004.07.998","volume":"45","author":"A Sasco","year":"2004","unstructured":"A. Sasco, M. Secretan, K. Straif, Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer 45, S3\u2013S9 (2004)","journal-title":"Lung Cancer"},{"key":"442_CR147","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/jcm5040044","volume":"5","author":"T Vu","year":"2016","unstructured":"T. Vu, L. Jin, P. Datta, Effect of cigarette smoking on epithelial to mesenchymal transition (EMT) in lung cancer. J Clin Med. 5, 44 (2016)","journal-title":"J Clin Med."},{"key":"442_CR148","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/ptr.5844","volume":"31","author":"Z Liang","year":"2017","unstructured":"Z. Liang, R. Wu, W. Xie, C. Xie, J. Wu, S. Geng, X. Li, M. Zhu, W. Zhu, J. Zhu, Effects of Curcumin on Tobacco Smoke-induced Hepatic MAPK Pathway Activation and Epithelial\u2013Mesenchymal Transition In Vivo. Phytother Res. 31, 1230\u20131239 (2017)","journal-title":"Phytother Res."},{"key":"442_CR149","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0092-8674(01)00330-0","volume":"105","author":"AH Huber","year":"2001","unstructured":"A.H. Huber, W.I. Weis, The structure of the \u03b2-catenin\/E-cadherin complex and the molecular basis of diverse ligand recognition by \u03b2-catenin. Cell 105, 391\u2013402 (2001)","journal-title":"Cell"},{"key":"442_CR150","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/jcmm.12033","volume":"17","author":"R Thakur","year":"2013","unstructured":"R. Thakur, D.P. Mishra, Pharmacological modulation of beta-catenin and its applications in cancer therapy. J Cell Mol Med. 17, 449\u2013456 (2013)","journal-title":"J Cell Mol Med."},{"key":"442_CR151","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10549-010-1089-3","volume":"128","author":"EM Al-Hujaily","year":"2011","unstructured":"E.M. Al-Hujaily, A.G. Mohamed, I. Al-Sharif, K.M. Youssef, P.S. Manogaran, B. Al-Otaibi, A. Al-Haza\u2019a, I. Al-Jammaz, K. Al-Hussein, A. Aboussekhra, PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells. Breast Cancer Res Treat. 128, 97\u2013107 (2011)","journal-title":"Breast Cancer Res Treat."},{"key":"442_CR152","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1186\/s12885-016-2583-8","volume":"16","author":"HA Al-Howail","year":"2016","unstructured":"H.A. Al-Howail, H.A. Hakami, B. Al-Otaibi, A. Al-Mazrou, M.H. Daghestani, I. Al-Jammaz, H.H. Al-Khalaf, A. Aboussekhra, PAC down-regulates estrogen receptor alpha and suppresses epithelial-to-mesenchymal transition in breast cancer cells. BMC Cancer 16, 540 (2016)","journal-title":"BMC Cancer"},{"key":"442_CR153","first-page":"1243","volume":"19","author":"P Paramita","year":"2018","unstructured":"P. Paramita, B.W. Wardhani, S.I. Wanandi, M. Louisa, Curcumin for the Prevention of Epithelial-Mesenchymal Transition in Endoxifen-Treated MCF-7 Breast Cancer Cells. Asian Pac J Cancer Prev. 19, 1243 (2018)","journal-title":"Asian Pac J Cancer Prev."},{"key":"442_CR154","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13046-016-0487-8","volume":"36","author":"J Xu","year":"2017","unstructured":"J. Xu, D. Liu, H. Niu, G. Zhu, Y. Xu, D. Ye, J. Li, Q. Zhang, Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN\/Akt signaling pathway in gastric cancer. Clin Cancer Res. 36, 19 (2017)","journal-title":"Clin Cancer Res."},{"key":"442_CR155","doi-asserted-by":"publisher","first-page":"11817","DOI":"10.1021\/jf404092f","volume":"61","author":"W-C Chen","year":"2013","unstructured":"W.-C. Chen, Y.-A. Lai, Y.-C. Lin, J.-W. Ma, L.-F. Huang, N.-S. Yang, C.-T. Ho, S.-C. Kuo, T.-D. Way, Curcumin suppresses doxorubicin-induced epithelial\u2013mesenchymal transition via the inhibition of TGF-\u03b2 and PI3K\/AKT signaling pathways in triple-negative breast cancer cells. J Agric Food Chem. 61, 11817\u201311824 (2013)","journal-title":"J Agric Food Chem."},{"key":"442_CR156","first-page":"5449","volume":"37","author":"R Bakalova","year":"2017","unstructured":"R. Bakalova, Z. Zhelev, S. Shibata, B. Nikolova, I. Aoki, T. Higashi, Impressive Suppression of Colon Cancer Growth by Triple Combination SN38\/EF24\/Melatonin:\u201cOncogenic\u201d Versus \u201cOnco-Suppressive\u201d Reactive Oxygen Species. Anticancer Res. 37, 5449\u20135458 (2017)","journal-title":"Anticancer Res."},{"key":"442_CR157","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/jop.12609","volume":"46","author":"W Ren","year":"2017","unstructured":"W. Ren, L. Gao, F. Li, C. Qiang, S. Li, J. Zheng, X. Kong, J. Deng, G. Cai, H. Zhang, Circulating high mobility group AT-hook 2 and pleomorphic adenoma gene 1 in blood of patients with oral squamous cell carcinoma. J Oral Pathol Med. 46, 998\u20131003 (2017)","journal-title":"J Oral Pathol Med."},{"key":"442_CR158","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1477-7819-10-92","volume":"10","author":"Q Zou","year":"2012","unstructured":"Q. Zou, L. Xiong, Z. Yang, F. Lv, L. Yang, X. Miao, Expression levels of HMGA2 and CD9 and its clinicopathological significances in the benign and malignant lesions of the gallbladder. World J Surg Oncol. 10, 92 (2012)","journal-title":"World J Surg Oncol."},{"key":"442_CR159","doi-asserted-by":"publisher","first-page":"5657","DOI":"10.1073\/pnas.91.12.5657","volume":"91","author":"MJ Scanlan","year":"1994","unstructured":"M.J. Scanlan, B. Raj, B. Calvo, P. Garin-Chesa, M.P. Sanz-Moncasi, J.H. Healey, L.J. Old, W.J. Rettig, Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci USA 91, 5657\u20135661 (1994)","journal-title":"Proc Natl Acad Sci USA"},{"key":"442_CR160","doi-asserted-by":"crossref","first-page":"25932","DOI":"10.18632\/oncotarget.4577","volume":"6","author":"G-M Jiang","year":"2015","unstructured":"G.-M. Jiang, W.-Y. Xie, H.-S. Wang, J. Du, B.-P. Wu, W. Xu, H.-F. Liu, P. Xiao, Z.-G. Liu, H.-Y. Li, Curcumin combined with FAP\u03b1c vaccine elicits effective antitumor response by targeting indolamine-2, 3-dioxygenase and inhibiting EMT induced by TNF-\u03b1 in melanoma. Oncotarget 6, 25932 (2015)","journal-title":"Oncotarget"},{"key":"442_CR161","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1172\/JCI0215518","volume":"110","author":"M Iwano","year":"2002","unstructured":"M. Iwano, D. Plieth, T.M. Danoff, C. Xue, H. Okada, E.G. Neilson, Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest. 110, 341\u2013350 (2002)","journal-title":"J Clin Invest."},{"key":"442_CR162","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1172\/JCI200320530","volume":"112","author":"R Kalluri","year":"2003","unstructured":"R. Kalluri, E.G. Neilson, Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest. 112, 1776\u20131784 (2003)","journal-title":"J Clin Invest."},{"key":"442_CR163","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1365-2613.2011.00764.x","volume":"92","author":"S Meran","year":"2011","unstructured":"S. Meran, R. Steadman, Fibroblasts and myofibroblasts in renal fibrosis. Int J Exp Pathol. 92, 158\u2013167 (2011)","journal-title":"Int J Exp Pathol."},{"key":"442_CR164","doi-asserted-by":"crossref","unstructured":"M. Zeisberg, J.S. Duffield, Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol. 21, 1247\u20131253 (2010)","DOI":"10.1681\/ASN.2010060616"},{"key":"442_CR165","doi-asserted-by":"publisher","first-page":"i37","DOI":"10.1093\/ndt\/gft267","volume":"29","author":"I Loeffler","year":"2013","unstructured":"I. Loeffler, G. Wolf, Transforming growth factor-\u03b2 and the progression of renal disease. Dial Transplant. 29, i37\u2013i45 (2013)","journal-title":"Dial Transplant."},{"key":"442_CR166","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cjtee.2015.08.005","volume":"19","author":"MR Farahpour","year":"2016","unstructured":"M.R. Farahpour, A. Dilmaghanian, M. Faridy, E. Karashi, Topical Moltkia coerulea hydroethanolic extract accelerates the repair of excision wound in a rat model. Chin J Traumatol. 19, 97\u2013103 (2016)","journal-title":"Chin J Traumatol."},{"key":"442_CR167","first-page":"2172","volume":"63","author":"SJ Grille","year":"2003","unstructured":"S.J. Grille, A. Bellacosa, J. Upson, A.J. Klein-Szanto, F. Van Roy, W. Lee-Kwon, M. Donowitz, P.N. Tsichlis, L. Larue, The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res. 63, 2172\u20132178 (2003)","journal-title":"Cancer Res."},{"key":"442_CR168","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.biopha.2014.10.005","volume":"68","author":"L-n Sun","year":"2014","unstructured":"L.-n. Sun, Z.-x. Chen, X.-c. Liu, H.-y. Liu, G.-j. Guan, G. Liu, Curcumin ameliorates epithelial-to-mesenchymal transition of podocytes in vivo and in vitro via regulating caveolin-1. Biomed Pharmacother. 68, 1079\u20131088 (2014)","journal-title":"Biomed Pharmacother."},{"key":"442_CR169","doi-asserted-by":"publisher","first-page":"23368","DOI":"10.1074\/jbc.M002020200","volume":"275","author":"F Galbiati","year":"2000","unstructured":"F. Galbiati, A.M. Brown, D.E. Weinstein, A. Ben-Ze'ev, R.G. Pestell, M.P. Lisanti, Caveolin-1 expression inhibits Wnt\/\u03b2-catenin\/Lef-1 signaling by recruiting \u03b2-catenin to caveolae membrane domains. J Biol Chem. 275, 23368\u201323377 (2000)","journal-title":"J Biol Chem."},{"key":"442_CR170","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/cvr\/cvr256","volume":"93","author":"R Kronstein","year":"2011","unstructured":"R. Kronstein, J. Seebach, S. Gro\u00dfklaus, C. Minten, B. Engelhardt, M. Drab, S. Liebner, Y. Arsenijevic, A.A. Taha, T. Afanasieva, Caveolin-1 opens endothelial cell junctions by targeting catenins. Cardiovasc Res. 93, 130\u2013140 (2011)","journal-title":"Cardiovasc Res."},{"key":"442_CR171","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1002\/jcp.25794","volume":"232","author":"A Bahrami","year":"2017","unstructured":"A. Bahrami, S. Shahidsales, M. Khazaei, M. Ghayour-Mobarhan, M. Maftouh, S.M. Hassanian, A. Avan, C-Met as a potential target for the treatment of gastrointestinal cancer: Current status and future perspectives. J Cell Physiol. 232, 2657\u20132673 (2017)","journal-title":"J Cell Physiol."},{"key":"442_CR172","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1172\/JCI70982","volume":"124","author":"JB Wu","year":"2014","unstructured":"J.B. Wu, C. Shao, X. Li, Q. Li, P. Hu, C. Shi, Y. Li, Y.-T. Chen, F. Yin, C.-P. Liao, Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis. J Clin Invest. 124, 2891\u20132908 (2014)","journal-title":"J Clin Invest."},{"key":"442_CR173","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/mc.22177","volume":"54","author":"X Chen","year":"2015","unstructured":"X. Chen, H. Cheng, T. Pan, Y. Liu, Y. Su, C. Ren, D. Huang, X. Zha, C. Liang, mTOR regulate EMT through RhoA and Rac1 pathway in prostate cancer. Mol Carcinog. 54, 1086\u20131095 (2015)","journal-title":"Mol Carcinog."},{"key":"442_CR174","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1093\/carcin\/bgn216","volume":"29","author":"S Cannito","year":"2008","unstructured":"S. Cannito, E. Novo, A. Compagnone, L. Valfr\u00e8 di Bonzo, C. Busletta, E. Zamara, C. Paternostro, D. Povero, A. Bandino, F. Bozzo, Redox mechanisms switch on hypoxia-dependent epithelial\u2013mesenchymal transition in cancer cells. Carcinogenesis 29, 2267\u20132278 (2008)","journal-title":"Carcinogenesis"},{"key":"442_CR175","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.4161\/cc.7.14.6324","volume":"7","author":"M-H Yang","year":"2008","unstructured":"M.-H. Yang, K.-J. Wu, TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development. Cell Cycle 7, 2090\u20132096 (2008)","journal-title":"Cell Cycle"},{"key":"442_CR176","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3892\/ijo.2017.3887","volume":"50","author":"Z Liu","year":"2017","unstructured":"Z. Liu, J. Liu, L. Zhao, H. Geng, J. Ma, Z. Zhang, D. Yu, C. Zhong, Curcumin reverses benzidine-induced epithelial-mesenchymal transition via suppression of ERK5\/AP-1 in SV-40 immortalized human urothelial cells. Int J Oncol. 50, 1321\u20131329 (2017)","journal-title":"Int J Oncol."},{"key":"442_CR177","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.canlet.2014.05.011","volume":"351","author":"SM Sureban","year":"2014","unstructured":"S.M. Sureban, R. May, N. Weygant, D. Qu, P. Chandrakesan, E. Bannerman-Menson, N. Ali, P. Pantazis, C.B. Westphalen, T.C. Wang, XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism. Cancer Lett. 351, 151\u2013161 (2014)","journal-title":"Cancer Lett."},{"key":"442_CR178","doi-asserted-by":"publisher","first-page":"e3066","DOI":"10.1038\/cddis.2017.452","volume":"8","author":"Z Liang","year":"2017","unstructured":"Z. Liang, L. Lu, J. Mao, X. Li, H. Qian, W. Xu, Curcumin reversed chronic tobacco smoke exposure induced urocystic EMT and acquisition of cancer stem cells properties via Wnt\/\u03b2-catenin. Cell Death Dis. 8, e3066 (2017)","journal-title":"Cell Death Dis."},{"key":"442_CR179","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1158\/1055-9965.EPI-06-0021","volume":"15","author":"C Samanic","year":"2006","unstructured":"C. Samanic, M. Kogevinas, M. Dosemeci, N. Malats, F.X. Real, M. Garcia-Closas, C. Serra, A. Carrato, R. Garc\u00eda-Closas, M. Sala, Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev. 15, 1348\u20131354 (2006)","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"442_CR180","first-page":"199","volume":"304","author":"W Zou","year":"2012","unstructured":"W. Zou, Y. Zou, Z. Zhao, B. Li, P. Ran, Nicotine Induced Epithelial-Mesenchymal Transition via Wnt\/\u03b2-catenin Signaling in Human Airway Epithelial Cells. Am J Physiol Heart Circ Physiol. 304, 199\u2013209 (2012)","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"442_CR181","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/jnci\/91.14.1194","volume":"91","author":"SS Hecht","year":"1999","unstructured":"S.S. Hecht, Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 91, 1194\u20131210 (1999)","journal-title":"J Natl Cancer Inst."},{"key":"442_CR182","first-page":"711","volume":"29","author":"C-C Yu","year":"2015","unstructured":"C.-C. Yu, M.-D. Yang, H.-Y. Lin, A.-C. Huang, J.-P. Lin, C.-L. Kuo, K.-C. Liu, H.-C. Liu, S.-T. Yang, J.-G. Chung, Bisdemethoxycurcumin (BDMC) alters gene expression-associated cell cycle, cell migration and invasion and tumor progression in human lung cancer NCI-H460 cells. In Vivo 29, 711\u2013728 (2015)","journal-title":"In Vivo"},{"key":"442_CR183","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0161-6420(83)34588-7","volume":"90","author":"G Hilton","year":"1983","unstructured":"G. Hilton, R. Machemer, R. Michels, E. Okun, C. Schepens, A. Schwartz, The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 90, 121\u2013125 (1983)","journal-title":"Ophthalmology"},{"key":"442_CR184","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00417-013-2531-0","volume":"252","author":"RM Feist","year":"2014","unstructured":"R.M. Feist, J.L. King, R. Morris, C.D. Witherspoon, C. Guidry, Myofibroblast and extracellular matrix origins in proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol. 252, 347\u2013357 (2014)","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"442_CR185","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.survophthal.2012.12.004","volume":"58","author":"JG Garweg","year":"2013","unstructured":"J.G. Garweg, C. Tappeiner, M. Halberstadt, Pathophysiology of proliferative vitreoretinopathy in retinal detachment. Surv Ophthalmol. 58, 321\u2013329 (2013)","journal-title":"Surv Ophthalmol."},{"key":"442_CR186","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1001\/archopht.1985.01050090155053","volume":"103","author":"PA Campochiaro","year":"1985","unstructured":"P.A. Campochiaro, J.A. Jerdan, B.M. Glaser, A. Cardin, R.G. Michels, Vitreous aspirates from patients with proliferative vitreoretinopathy stimulate retinal pigment epithelial cell migration. Arch Ophthalmol. 103, 1403\u20131405 (1985)","journal-title":"Arch Ophthalmol."},{"key":"442_CR187","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13643-016-0284-7","volume":"5","author":"R Chaudhary","year":"2016","unstructured":"R. Chaudhary, J. Dretzke, R. Scott, A. Logan, R. Blanch, Clinical and surgical risk factors in the development of proliferative vitreoretinopathy following retinal detachment surgery: a systematic review protocol. Syst Rev. 5, 107 (2016)","journal-title":"Syst Rev."},{"key":"442_CR188","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.sjopt.2014.03.005","volume":"28","author":"S Ganekal","year":"2014","unstructured":"S. Ganekal, S. Dorairaj, Effect of intraoperative 5-fluorouracil and low molecular weight heparin on the outcome of high-risk proliferative vitreoretinopathy. Saudi J Ophthalmol. 28, 257\u2013261 (2014)","journal-title":"Saudi J Ophthalmol."}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-019-00442-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13402-019-00442-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-019-00442-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T21:50:52Z","timestamp":1721166652000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13402-019-00442-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,13]]},"references-count":188,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["442"],"URL":"https:\/\/doi.org\/10.1007\/s13402-019-00442-2","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,13]]},"assertion":[{"value":"21 March 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Muhammed Majeed is the founder of Sabinsa Corporation and Sami Labs Ltd. Other authors have no direct competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}